Mantle Cell Lymphoma Clinical Trials in Columbus

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
J
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Enrolling by invitation
  • Chronic Lymphocytic Leukemia
  • +6 more
  • Duarte, California
  • +165 more
2022-03-24
Mar 24, 2022
C
Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
Active, not recruiting
  • Adult Immunoblastic Lymphoma
  • +12 more
  • Cytology Specimen Collection Procedure
  • Birmingham, Alabama
  • +129 more
2022-03-23
Mar 23, 2022
T
Study to Assess the Efficacy and Safety of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Active, not recruiting
  • Diffuse Large B-Cell Lymphoma
  • +4 more
  • Ublituximab
  • +2 more
  • Birmingham, Alabama
  • +167 more
2022-03-22
Mar 22, 2022
A
A Study of Nemtabrutinib (MK-1026) (ARQ 531) in Participants With Selected Hematologic Malignancies
Active, not recruiting
  • Lymphoma, B-Cell
  • +8 more
  • Scottsdale, Arizona
  • +9 more
2022-03-10
Mar 10, 2022
A
A Disease Registry of Patients With Mantle Cell Lymphoma
Recruiting
  • Mantle Cell Lymphoma
    • Decatur, Alabama
    • +53 more
    2022-03-04
    Mar 4, 2022
    L
    A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL
    Recruiting
    • Chronic Lymphocytic Leukemia
    • +5 more
    • Scottsdale, Arizona
    • +55 more
    2022-01-12
    Jan 12, 2022
    E
    Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission
    Recruiting
    • CD20 Positive
    • Mantle Cell Lymphoma
    • Autologous Hematopoietic Stem Cell Transplantation
    • +2 more
    • Birmingham, Alabama
    • +318 more
    2021-12-22
    Dec 22, 2021
    M
    Double Cord Versus Haploidentical (BMT CTN 1101) - 2020
    Completed
    Has Results
    • Acute Lymphocytic Leukemia
    • +6 more
    • Haploidentical Bone Marrow Transplant
    • Double Umbilical Cord Blood Transplant
    • Birmingham, Alabama
    • +38 more
    2021-11-02
    Nov 2, 2021
    N
    Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
    Recruiting
    • CLL/SLL
    • +6 more
    • Cincinnati, Ohio
    • +2 more
    2021-11-02
    Nov 2, 2021
    U
    Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
    Active, not recruiting
    • Mantle Cell Lymphoma
    • Duarte, California
    • +2 more
    2021-10-01
    Oct 1, 2021
    G
    Phase I Dose Escalation Study of IMMU-114 in Relapsed or Refractory NHL and CLL - 2017
    Terminated
    • Non-hodgkin's Lymphoma
    • +5 more
    • Newark, Delaware
    • +4 more
    2021-08-12
    Aug 12, 2021
    A
    Bortezomib After Combination Chemotherapy, Rituximab, and an Autologous Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma
    Active, not recruiting
    Has Results
    • Mantle Cell Lymphoma
    • San Francisco, California
    • +47 more
    2021-08-16
    Aug 16, 2021
    A
    Phase II Palbociclib +Ibrutinib in Mantle Cell Lymphoma
    Recruiting
    • Mantle Cell Lymphoma
    • B Cell Lymphoma
    • Duarte, California
    • +10 more
    2021-07-19
    Jul 19, 2021
    E
    A Comparison of Three Chemotherapy Regimens for the Treatment of Patients With Newly Diagnosed Mantle Cell Lymphoma
    Recruiting
    • Liver Lymphoma
    • Mantle Cell Lymphoma
    • Anchorage, Alaska
    • +392 more
    2021-07-15
    Jul 15, 2021
    G
    Study to Evaluate Efficacy, Safety, Tolerability, and Pharmacodynamics of Entospletinib in Adults With Relapsed or Refractory Hematologic Malignancies - 2020
    Terminated
    Has Results
    • Chronic Lymphocytic Leukemia
    • +4 more
    • Entospletinib MM
    • Entospletinib SDD
    • Birmingham, Alabama
    • +47 more
    2020-11-02
    Nov 2, 2020
    P
    Safety and Tolerability Study of PCI-32765 in B Cell Lymphoma and Chronic Lymphocytic Leukemia - 2019
    Completed
    Has Results
    • B-cell Chronic Lymphocytic Leukemia
    • +9 more
    • Stanford, California
    • +15 more
    2020-05-14
    May 14, 2020
    O
    Velcade (Bortezomib, PS-341) and Rituximab in Relapsed/Refractory Mantle Cell and Follicular Non-Hodgkin's Lymphoma - 2012
    Completed
    Has Results
    • Non-Hodgkin's Lymphoma
    • Mantle Cell Lymphoma
    • Columbus, Ohio
      Ohio State University Medical Center
    2018-03-07
    Mar 7, 2018
    T
    Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) - Referred to as the BRIGHT Study - 2012
    Completed
    Has Results
    • Non-Hodgkin's Lymphoma
    • Mantle Cell Lymphoma
    • Tucson, Arizona
    • +127 more
    2018-01-08
    Jan 8, 2018
    C
    A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers - 2017
    Completed
    • CD27 Expressing B-cell Malignancies for Example Hodgkin's Lymphoma
    • +9 more
    • Scottsdale, Arizona
    • +9 more
    2018-01-29
    Jan 29, 2018
    P
    Safety and Efficacy of PCI-32765 in Participants With Relapsed/Refractory Mantle Cell Lymphoma (MCL) - 2014
    Completed
    Has Results
    • Mantle Cell Lymphoma
    • Stanford, California
    • +17 more
    2015-08-24
    Aug 24, 2015
    C
    Study to Assess the Effect of Treatment With Bendamustine in Combination With Rituximab on QT Interval in Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) - 2012
    Completed
    Has Results
    • Non-Hodgkin's Lymphoma
    • Mantle Cell Lymphoma
    • Tucson, Arizona
    • +42 more
    2014-04-07
    Apr 7, 2014